drugset / Trial / NCT06877702

A Single-dose Study to Evaluate the Safety, Tolerability, Drug Levels, and Relative Biological Availability of Alternate Formulations of BMS-986460 in Healthy Adult Male Participants

NCT06877702 ↗

Phase 1 Completed 85 enrolled Bristol-Myers Squibb
RandomizedCrossoverOpen-labelTreatment

Summary

The purpose of this study is to assess the safety, tolerability, drug levels, and relative bioavailability of alternate formulations of BMS-986460 in healthy adult male participants.

Timeline

Start
2025-03-19
Primary completion
2025-12-17
Completion
2025-12-17

Drugs

EvaluationDrugModalityDoseRoute
Subject BMS-986460 Unknown — —

Indications

No indication recorded.